Heme oxygenase-2 gene deletion attenuates oxidative stress in neurons exposed to extracellular hemin
© Regan et al; licensee BioMed Central Ltd. 2004
Received: 30 June 2004
Accepted: 17 September 2004
Published: 17 September 2004
Hemin, the oxidized form of heme, accumulates in intracranial hematomas and is a potent oxidant. Growing evidence suggests that it contributes to delayed injury to surrounding tissue, and that this process is affected by the heme oxygenase enzymes. In a prior study, heme oxygenase-2 gene deletion increased the vulnerability of cultured cortical astrocytes to hemin. The present study tested the effect of HO-2 gene deletion on protein oxidation, reactive oxygen species formation, and cell viability after mixed cortical neuron/astrocyte cultures were incubated with neurotoxic concentrations of hemin.
Continuous exposure of wild-type cultures to 1–10 μM hemin for 14 h produced concentration-dependent neuronal death, as detected by both LDH release and fluorescence intensity after propidium iodide staining, with an EC50 of 1–2 μM; astrocytes were not injured by these low hemin concentrations. Cell death was consistently reduced by at least 60% in knockout cultures. Exposure to hemin for 4 hours, a time point that preceded cell lysis, increased protein oxidation in wild-type cultures, as detected by staining of immunoblots for protein carbonyl groups. At 10 μM hemin, carbonylation was increased 2.3-fold compared with control sister cultures subjected to medium exchanges only; this effect was reduced by about two-thirds in knockout cultures. Cellular reactive oxygen species, detected by fluorescence intensity after dihydrorhodamine 123 (DHR) staining, was markedly increased by hemin in wild-type cultures and was localized to neuronal cell bodies and processes. In contrast, DHR fluorescence intensity in knockout cultures did not differ from that of sham-washed controls. Neuronal death in wild-type cultures was almost completely prevented by the lipid-soluble iron chelator phenanthroline; deferoxamine had a weaker but significant effect.
These results suggest that HO-2 gene deletion protects neurons in mixed neuron-astrocyte cultures from heme-mediated oxidative injury. Selective inhibition of neuronal HO-2 may have a beneficial effect after CNS hemorrhage.
Hemin is a potent oxidant that accumulates in intracranial hematomas and may contribute to neural cell injury [1, 2]. It is also the preferred substrate for heme oxygenase-2, the constitutively-expressed isoform that accounts for most CNS heme oxygenase (HO) under normal conditions . In pathologic states, HO frequently has an antioxidant effect, putatively due to the protection provided by increased cellular bilirubin, decreased heme, and up-regulation of other antioxidants [4–7]. However, in models that are relevant to CNS hemorrhage, HO inhibitors have surprisingly been found to be protective [8–10].
All HO inhibitors that are currently available have numerous non-specific actions that may complicate the interpretation of experimental results, including inhibition of nitric oxide synthase and guanyl cyclase, and modification of voltage-gated calcium currents [11–14]. Some may also have a direct antioxidant effect that is unrelated to HO inhibition . In order to investigate HO-2 in heme-mediated injury more specifically, we have cultured neurons and astrocytes derived from HO-2 knockout mice and genetically-similar wild type controls. In recent studies, we observed that astrocytes derived from mutant mice were more vulnerable to hemin . Conversely, HO-2 gene deletion decreased the vulnerability of neurons to hemoglobin . Neither wild type nor knockout astrocytes were injured by hemoglobin at the micromolar concentrations that are feasible in vitro. HO-2 gene deletion per se did not result in a compensatory increase in HO-1 in these cultures, and produced minimal or no change in other cellular antioxidants [16, 17].
The disparate effects of HO-2 gene deletion on hemin toxicity to astrocytes and hemoglobin toxicity to neurons may reflect the inability of neurons to tolerate the products of heme metabolism, i.e. iron, carbon monoxide, and bilirubin. Alternatively, it may reflect the different oxidant properties of hemin and hemoglobin. Although the oxidant effect of hemoglobin may be due in part to hemin release to membrane lipids , other mechanisms may also contribute. Extracellular hemoglobin undergoes autoxidation, which produces superoxide . In addition to being an oxidant, superoxide reacts with globin amino acids in a complex fashion to generate a variety of reactive species, including thiyl radicals, hydroxyl radicals, and hydrogen peroxide [20, 21]. It is also noteworthy that hemoglobin is highly water soluble while hemin is quite lipophilic; their accumulation in separate cellular compartments may lead to a different pattern of site-specific oxidative damage [22, 23].
The present study was designed to test the effect of HO-2 gene deletion on the oxidative neuronal injury produced by extracellular hemin. We specifically tested the hypothesis that targeted deletion of the HO-2 gene attenuated oxidative cell injury in a primary cell culture model of hemin toxicity.
Effect of HO-2 gene deletion on hemin neurotoxicity
Cell death was also quantified by analysis of fluorescence intensity after staining cultures with propidium iodide. Using this method, widespread neuronal death was also observed at 3–10 μM hemin in wild type cultures, and the calculated EC50 was 1.05 μM. Propidium staining of nuclei was significantly reduced in cultures prepared from HO-2 knockout mice (Fig. 2B). The maximal fluorescence was produced by exposure to 10 μM hemin, which was 37.0 ± 3.2% of that observed in control sister cultures treated with NMDA to kill all neurons.
Effect of HO-2 gene deletion on markers of cell oxidation
Hemin neurotoxicity is attenuated by iron chelators
In prior experiments, we demonstrated that targeted deletion of the HO-2 gene in primary neuron/astrocyte cultures did not alter expression of HO-1, and had little or no effect on other cellular antioxidants . This simplified system therefore permits investigation of HO-2 without the confounding compensatory effects that have been observed in whole animal models [26, 27]. We have previously reported that HO-2 gene deletion increased the vulnerability of astrocytes to hemin, the preferred substrate of HO, in cultures containing only astrocytes. The present study targeted neurons in mixed neuron/astrocyte cultures by using hemin concentrations that did not injure astrocytes . In this model, the opposite was observed. HO-2 deletion attenuated hemin-induced ROS formation and reduced levels of oxidized proteins. Consistent with the oxidative nature of hemin toxicity, neuronal death was reduced in knockout cultures.
Although hemin is a highly reactive pro-oxidant, its breakdown as catalyzed by the heme oxygenases generates biologically active and potentially toxic products. Prior in vitro studies suggest that neurons are particularly vulnerable to these, i.e. iron, carbon monoxide, and bilirubin [28–30]. The present results suggest that when neurons are provided with an excess of HO substrate, the toxicity of breakdown products outweighs any benefit provided by hemin removal. The protective effect of iron chelators suggests that this phenomenon is at least partly due to iron neurotoxicity. Inorganic iron is toxic to cultured cortical neurons, with an EC50 of approximately 10 μM . The lower EC50 for hemin is not surprising, given its lipophilicity and accumulation in cell membranes . The latter phenomenon likely accounts for the greater efficacy of phenanthroline, which unlike deferoxamine is lipophilic. Deferoxamine is quite effective against hemoglobin neurotoxicity in this culture system , suggesting that hemoglobin releases its iron either in the medium or in an aqueous cellular compartment.
The present results are consistent with observations that heme oxygenase inhibitors are protective in models of CNS hemorrhage [2, 8, 9], in contrast to the beneficial effect of HO in ischemia . In a recent study, Koeppen et al.  observed that repeated administration of tin mesoporphyrin protected thalamic neurons from the delayed degeneration that occurred in tissue adjacent to injected autologous blood. Similarly, Huang et al.  observed that tin protoporphyrin attenuated edema formation after stereotactic hemoglobin injection into the rat striatum. It is noteworthy that the number of astrocytes per neuron is significantly higher in the human brain than in rodents . The deleterious effect of HO inhibition on heme mediated injury to astrocytes may therefore be less prominent in animal models than in clinical intracerebral hemorrhage .
The disparate effect of HO on neurons and astrocytes exposed to extracellular hemin suggests that it may be somewhat difficult to target it effectively after CNS hemorrhage. All currently available HO inhibitors inhibit both HO-2, which is predominantly neuronal in vivo , and HO-1, which is induced mainly in glial cells . The protection that these non-selective agents provide to neurons may be negated by their deleterious effect on astrocytes. Further investigation is needed for the development of strategies that would permit the selective inhibition or down-regulation of HO-2 in neurons.
Targeted deletion of the heme oxygenase-2 gene mitigates oxidative stress in cultured neurons exposed to hemin, and is cytoprotective. Selective inhibition of neuronal heme oxygenase may have a beneficial effect after CNS hemorrhage.
The HO-2 knockout mice which were used in this study are descended from mutants produced by Poss et al. , and have a C57BL/6 X 129/Sv genetic background. All mice were obtained from our local breeding colony, and were provided with food and water ad libitum and a 12 hour light/dark cycle. All breeding mice were the offspring of heterozygotes. Genotype was determined by polymerase chain reaction (PCR) using genomic DNA isolated from tail clippings; primers were previously published .
Cortical cell cultures were prepared from fetal mice at gestational age 15–17 d as previously described . Under a dissecting microscope, cortices were dissected free from other brain tissue, minced with forceps, and incubated in medium containing 0.075%-acetylated trypsin at 37°C for one hour. Tissue was then collected by low speed centrifugation, and was dissociated by trituration through a flamed Pasteur pipette in plating medium containing Eagle's minimal essential medium (MEM), 5% fetal bovine serum (Hyclone, Logan, UT), 5% heat inactivated equine serum (Hyclone), glutamine (2 mM), and glucose (23 mM). The cell suspension was diluted with additional plating medium, and cells were plated on confluent astrocyte cultures in 24-well plates (Primaria, Falcon) at a density of 3 hemispheres/plate. Cultures were incubated at 37°C in a humidified atmosphere containing 5% CO2/95% air. Two-thirds of the culture medium was replaced at days 4 and 8 in vitro with MEM containing 10% equine serum, 2 mM glutamine, and 23 mM glucose. After ten days in vitro this feeding procedure was performed daily.
Hemin was freshly prepared as a 1 mM stock solution and was diluted to the desired concentration with minimal essential medium containing 10 mM glucose (MEM10). Experiments were conducted at 12–16 days in vitro. Serum was washed out of cultures with MEM10 (> 1000X dilution) prior to addition of hemin. Cultures were incubated at 37°C in a 5% CO2 atmosphere for the entire exposure interval.
Detection of reactive oxygen species
ROS formation was quantified by staining with dihydrorhodamine 123 (DHR, Molecular Probes, Eugene, OR), which is a cell-permeable, non-fluorescent compound that is oxidized by cellular peroxides to fluorescent rhodamine . Fluorescence intensity is directly proportional to cellular oxidative stress. In order to prevent oxidation of DHR by hemin in the medium, cultures were washed free of hemin prior to DHR addition. After incubation with 20 μM DHR in MEM10 for 15 min, the medium was replaced, and cultures were imaged using a Nikon inverted microscope with epifluorescence attachment. Images were captured immediately after illumination (25 msec exposure). Photomicrographs of random 100X fields were analyzed with IPLab image analysis software (Scanalytics, Inc., Fairfax, VA). The low fluorescence in control cultures exposed to experimental medium only was subtracted from mean values to define the signal associated with hemin exposure.
Detection of protein oxidation
Protein oxidation was assessed using the Oxyblot™ kit (Chemicon, Inc., Temecula, CA). At the end of the hemin exposure interval, culture medium was aspirated, and cells were washed and then harvested in 100 μl of lysis buffer containing 210 mM mannitol, 70 mM sucrose, 5 mM HEPES, 1 mM EDTA, and 0.1% sodium dodecyl sulfate. Carbonyl groups were derivatized to 2, 4-dintrophenylhydrazone (DNP-hydrazone) by reaction with 2, 4-dinitrophenylhydrazine, following the manufacturer's instructions. Proteins were then separated on a 12% polyacrylamide gel and were transferred onto a polyvinylidene difluoride Imobilon-P transfer membrane filter (Millipore, Billerica, MA) using a semidry transfer apparatus (Bio-Rad, Hercules, CA). Carbonylated proteins were detected with rabbit anti-DNP (1:150) followed by goat anti-rabbit IgG (1:300). Immunoreactive proteins were visualized using Super Signal West Femto Reagent (Pierce Biotechnology, Rockford, IL) and Kodak ImageStation 400.
Quantification of cell death
After examination of cultures using phase contrast microscopy, cell death was quantified by measurement of LDH activity in the culture medium, as previously described . To facilitate comparisons, values were scaled to the mean value in sister cultures exposed to NMDA 300 μM for 40 h. This treatment releases essentially all neuronal LDH in this system without injuring astrocytes . Since the low micromolar concentrations of hemin that were used in this study do not injure cultured cortical astrocytes , the contribution of astrocyte LDH to the total signal is negligible.
Cell death was also quantified by staining with propidium iodide (13 μg/ml for 15 min). When viewed with a rhodamine filter, the nuclei of cells with disrupted membranes stain red, while cells with intact membranes exclude propidium. Random 100X fields were captured with a Nikon Diaphot epifluorescence microscope and were analyzed with IPLab image analysis software. As with LDH data, fluorescence intensity was scaled to that in sister cultures treated with NMDA 300 μM for 40 h, which kills all neurons. Propidium iodide fluorescence was not observed in cells that had an astrocyte phenotype after treatment with NMDA or hemin at the concentrations used in this study.
minimal essential medium containing 10 mM glucose
reactive oxygen species.
This study was supported by a grant from the National Institutes of Health (1RO1NS042273) and from the Pennsylvania/Delaware affiliate of the American Heart Association. We thank Dr. Frank Sharp for providing the HO-2 knockout mice that were used to establish our colony.
- Letarte PB, Lieberman K, Nagatani K, Haworth RA, Odell GB, Duff TA: Hemin: levels in experimental subarachnoid hematoma and effects on dissociated vascular smooth muscle cells. J Neurosurg. 1993, 79: 252-255.View ArticlePubMedGoogle Scholar
- Koeppen AH, Dickson AC, Smith J: Heme oxygenase in experimental intracerebral hemorrhage: the benefit oftin-mesoporphyrin. J Neuropathol Exp Neurol. 2004, 63: 587-597.PubMedGoogle Scholar
- Trakshel GM, Kutty RK, Maines MD: Resolution of rat brain heme oxygenase activity: absence of detectable amount of the inducible form (HO-1). Arch Biochem Biophys. 1988, 260: 732-739.View ArticlePubMedGoogle Scholar
- Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN: Bilirubin is an antioxidant of possible physiologic significance. Science. 1987, 235: 1043-1046.View ArticlePubMedGoogle Scholar
- Doré S, Takahashi M, Ferris CD, Hester LD, Guastella D, Snyder SH: Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA. 1999, 96: 2445-2450. 10.1073/pnas.96.5.2445.PubMed CentralView ArticlePubMedGoogle Scholar
- Taille C, El-Benna J, Lanone S, Dang MC, Ogier-Denis E, Aubier M, Boczkowski J: Induction of heme oxygenase-1 inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability. J Biol Chem. 2004, 279: 28681-28688. 10.1074/jbc.M310661200.View ArticlePubMedGoogle Scholar
- Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM: Ferritin: A cytoprotective strategem of endothelium. J Biol Chem. 1992, 267: 18148-18153.PubMedGoogle Scholar
- Wagner KR, Hua Y, de Courten-Myers GM, Broderick JP, Nishimura RN, Lu SY, Dwyer BE: Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies. Cell Mol Biol (Nolsy-le-grand). 2000, 46: 597-608.Google Scholar
- Huang FP, Xi G, Keep. RF, Hua Y, Nemoianu A, Hoff JT: Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg. 2002, 96: 287-293.View ArticlePubMedGoogle Scholar
- Wu J, Hua Y, Keep RF, Nakemura T, Hoff JT, Xi G: Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke. 2003, 34: 2964-2969. 10.1161/01.STR.0000103140.52838.45.View ArticlePubMedGoogle Scholar
- Linden DJ, Narisimhan K, Gurfel D: Protoporphyrins modulate voltage-gated calcium current in AtT-20 pituitary cells. J Neurophysiol. 1993, 70: 2673-2677.PubMedGoogle Scholar
- Luo D, Vincent SR: Metalloporphyrins inhibit nitric oxide-dependent cGMP formation in vivo. Eur J Pharmacol. 1994, 267: 263-267. 10.1016/0922-4106(94)90149-X.View ArticlePubMedGoogle Scholar
- Meffert MK, Haley JE, Schuman EM, Schulman H, Madison DV: Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins. Neuron. 1994, 13: 1225-1233. 10.1016/0896-6273(94)90060-4.View ArticlePubMedGoogle Scholar
- Grundemar L, Ny L: Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol Sci. 1997, 18: 193-195. 10.1016/S0165-6147(97)01065-1.View ArticlePubMedGoogle Scholar
- Wagner KR, Dwyer BE: Hematoma removal, heme, and heme oxygenase following hemorrhagic stroke. Ann NY Acad Sci. 2004, 1012: 237-251. 10.1196/annals.1306.020.View ArticlePubMedGoogle Scholar
- Chen J, Regan RF: Heme oxygenase-2 gene deletion increases astrocyte vulnerability to hemin. Biochem Biophys Res Commun. 2004, 318: 88-94. 10.1016/j.bbrc.2004.03.187.View ArticlePubMedGoogle Scholar
- Rogers B, Yakopson V, Teng ZP, Guo Y, Regan RF: Heme oxygenase-2 knockout neurons are less vulnerable to hemoglobin toxicity. Free Rad Biol Med. 2003, 35: 872-881. 10.1016/S0891-5849(03)00431-3.View ArticlePubMedGoogle Scholar
- Chiu D, Lubin B: Oxidative hemoglobin denaturation and RBC destruction: the effect of heme on red cell membranes. Sem In Hematol. 1989, 26: 128-135.Google Scholar
- Misra HP, Fridovich I: The generation of superoxide radical during the autoxidation of hemoglobin . J Biol Chem. 1972, 247: 6960-6962.PubMedGoogle Scholar
- Watkins JA, Kawanashi S, Caughey WS: Autoxidation reactions of hemoglobin A free from other red cell components: a minimal mechanism. Biochem Biophys Res Comm. 1985, 132: 742-748.View ArticlePubMedGoogle Scholar
- Balagopalakrishna C, Abugo OO, Horsky J, Manoharan PT, Nagababu E, Rifkind JM: Superoxide produced in the heme pocket of the beta-chain of hemoglobin reacts with the beta-93 cysteine to produce a thiyl radical. Biochemistry. 1998, 37: 13194-13202. 10.1021/bi980941c.View ArticlePubMedGoogle Scholar
- Samuni A, Aronivitch J, Godinger G, Chevion M, Czapski G: On the cytotoxicity of vitamin C and metal ions. A site-specific Fenton mechanism. Eur J Biochem. 1983, 137: 119-124.View ArticlePubMedGoogle Scholar
- Arouma OI, Grootveld M, Halliwell B: The role of iron in ascorbate-dependent deoxyribose degradation. Evidence consistent with a site-specific hydroxyl radical generation caused by iron ions bound to the deoxyribose molecule. J Inorg Chem. 1987, 29: 289-299.Google Scholar
- Regan RF, Kumar N, Gao F, Guo YP: Ferritin induction protects cortical astrocytes from heme-mediated oxidative injury. Neuroscience. 2002, 113: 985-994. 10.1016/S0306-4522(02)00243-9.View ArticlePubMedGoogle Scholar
- Goldstein L, Teng ZP, Zeserson E, Patel M, Regan RF: Hemin induces an iron-dependent, oxidative injury on human neuron-like cells. J Neurosci Res. 2003, 73: 113-121. 10.1002/jnr.10633.View ArticlePubMedGoogle Scholar
- Dennery PA, Spitz DR, Yang G, Tatarov A, Lee CS, Shegog ML, Poss KD: Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. J Clin Invest. 1998, 101: 1001-1011.PubMed CentralView ArticlePubMedGoogle Scholar
- Dennery PA, Visner G, Weng Y-H, Nguyen X, Lu F, Zander D, Yang G: Resistance to hyperoxia with heme oxygenase-1 disruption: role of iron. Free Radic Biol Med. 2003, 34: 124-133. 10.1016/S0891-5849(02)01295-9.View ArticlePubMedGoogle Scholar
- Liu R, Liu W, Doctrow SR, M. Baudry: Iron toxicity in organotypic cultures of hippocampal slices: role of reactive oxygen species. J Neurochem. 2003, 85: 492-502.View ArticlePubMedGoogle Scholar
- Miro O, Casademont J, Urbanomarquez A, Cardellach F: Mitochondrial cytochrome C oxidase inhibition during carbon monoxide poisoning. Pharmacology and Toxicology. 1998, 82: 199-202.View ArticlePubMedGoogle Scholar
- Silva RF, Rodriguez CM, Brites D: Rat cultured neuronal and glial cells respond differently to toxicity of unconjugated bilirubin. Pediatr Res. 2002, 51: 535-541.View ArticlePubMedGoogle Scholar
- Shaklai N, Shviro Y, Rabizadeh E, Kirschner-Zilber I: Accumulation and drainage of hemin in the red cell membrane. Biochim Biophys Acta. 1985, 821: 355-366. 10.1016/0005-2736(85)90106-3.View ArticlePubMedGoogle Scholar
- Regan RF, Panter SS: Neurotoxicity of hemoglobin in cortical cell culture. Neurosci Lett. 1993, 153: 219-222. 10.1016/0304-3940(93)90326-G.View ArticlePubMedGoogle Scholar
- Doré S, Sampei K, Goto S, Alkayed NJ, Guastella D, Blackshaw S, Gallagher M, Traystman RJ, Hurn PD, Koehler RC, Snyder SH: Heme oxygenase-2 is neuroprotective in cerebral ischemia. Mol Med. 1999, 5: 656-663.PubMedGoogle Scholar
- Nedergaard M, Ransom B, Goldman SA: New roles for astrocytes: Redefining the functional architecture of the brain. Trends Neurosci. 2003, 26: 523-530. 10.1016/j.tins.2003.08.008.View ArticlePubMedGoogle Scholar
- Regan RF, Guo YP, Kumar N: Heme oxygenase-1 induction protects murine cortical astrocytes from hemoglobin toxicity. Neurosci Lett. 2000, 282: 1-4. 10.1016/S0304-3940(00)00817-X.View ArticlePubMedGoogle Scholar
- Ewing JF, Maines MD: In situ hybridization and immunohistochemical localization of heme oxygenase-2 mRNA and protein in normal rat brain: differential distribution of isozyme 1 and 2. Mol Cell Neurosci. 1992, 3: 559-570.View ArticlePubMedGoogle Scholar
- Matz P, Turner C, Weinstein PR, Massa SM, Panter SS, Sharp FR: Heme-oxygenase-1 induction in glia throughout rat brain following experimental subarachnoid hemorrhage. Brain Res. 1996, 713: 211-222. 10.1016/0006-8993(95)01511-6.View ArticlePubMedGoogle Scholar
- Poss KD, Thomas MJ, Ebralidze AK, TJ OD, Tonegawa S: Hippocampal long-term potentiation is normal in heme oxygenase-2 mutant mice. Neuron. 1995, 15: 867-873. 10.1016/0896-6273(95)90177-9.View ArticlePubMedGoogle Scholar
- Regan RF, Choi DW: The effect of NMDA, AMPA/kainate, and calcium channel antagonists on traumatic cortical neuronal injury in culture. Brain Res. 1994, 633: 236-242. 10.1016/0006-8993(94)91544-X.View ArticlePubMedGoogle Scholar
- Royall JA, Ischiropoulos H: Evaluation of 2',7'-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch Biochem Biophys. 1993, 302: 348-355. 10.1006/abbi.1993.1222.View ArticlePubMedGoogle Scholar
- Regan RF, Rogers B: Delayed treatment of hemoglobin neurotoxicity. J Neurotrauma. 2003, 20: 111-120. 10.1089/08977150360517236.View ArticlePubMedGoogle Scholar
- Koh JY, Choi DW: Vulnerability of cultured cortical neurons to damage by excitotoxins: Differential susceptibility of neurons containing NADPH-diaphorase. J Neurosci. 1988, 8: 2153-2163.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.